Clinical trials
Observational Delirium trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Active, not recruiting | 8 |
| Recruiting | 6 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt University Medical Center | 6 |
| Stanford University | 5 |
| Ohio State University | 4 |
| Vanderbilt University | 4 |
| Johns Hopkins University | 3 |
| University of Chicago | 3 |
| University of Florida | 3 |
| Brigham and Women's Hospital | 2 |
| Ceribell Inc. | 2 |
| Massachusetts General Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Delirium | 66 |
| Cognitive Dysfunction | 12 |
| Critical Illness | 8 |
| Dementia | 8 |
| Confusion | 6 |
| Emergence Delirium | 5 |
| Pain | 5 |
| Brain Diseases | 4 |
| Alzheimer Disease | 3 |
| Stroke | 3 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.